Convelo Therapeutics, Inc.

DUBLIN, May 11, 2023 /PRNewswire/ -- The "Global Central Nervous System Partnering 2016-2023: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering. Global Central Nervous System Partnering 2016 to 2010 provides the full collection of central nervous system disease deals signed between the world's pharmaceutical and biotechnology companies since 2016. Trends in central nervous system partnering deals Financial deal terms for headline, upfront and royalty by stage of development Central Nervous System partnering agreement structure Central Nervous System partnering contract documents Top central nervous system deals by value Most active central nervous system dealmakers Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element. The report takes readers through the comprehensive central nervous system disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering central nervous system deals. The report presents financial deal terms values for central nervous system deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals. The initial chapters of this report provide an orientation of central nervous system dealmaking trends. Chapter 1 provides an introduction to the report. Chapter 2 provides an overview of the trends in central nervous system dealmaking since 2016 covering trends by year, deal type, stage of development, technology type and therapeutic indication. Chapter 3 includes an analysis of financial deal terms covering headline value, upfront payment, milestone payments and royalty rates. Chapter 4 provides a review of the leading central nervous system deals since 2016. Deals are listed by headline value. The chapter includes the top 25 most active central nervous system dealmakers, together with a full listing of deals to which they are a party. Where the deal has an agreement contract published at the SEC a link provides online access to the contract. Chapter 5 provides comprehensive access to central nervous system deals since 2016 where a deal contract is available, providing the user with direct access to contracts as filed with the SEC regulatory authorities. Each deal title links via Weblink to an online version of the deal record contract document, providing easy access to each contract document on demand. Chapter 6 provides a comprehensive directory of all central nervous system partnering deals by specific central nervous system target announced since 2016. The chapter is organized by specific central nervous system therapeutic target. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. In addition, a comprehensive appendix is provided with each report of all central nervous system partnering deals signed and announced since 2016. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The report also includes numerous tables and figures that illustrate the trends and activities in central nervous system partnering and dealmaking since 2016. In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of central nervous system technologies and products. Report scope Global Central Nervous System Partnering 2016 to 2023 is intended to provide the reader with an in-depth understanding and access to central nervous system trends and structure of deals entered into by leading companies worldwide. Global Central Nervous System Partnering 2016 to 2023 includes: Trends in central nervous system dealmaking in the biopharma industry since 2016 Access to headline, upfront, milestone and royalty data Access to hundreds of central nervous system deal contract documents Comprehensive access to over 1,700 central nervous system deal records The leading central nervous system deals by value since 2016 Most active central nervous system dealmakers since 2016 The report includes deals for the following indications: Cerebral palsy, Creutzfeldt Jakob disease, Dizziness, Epilepsy, Faints, Falls, Guillain Barre syndrome, Headache, Meningitis (Bacterial, Meningococcal, Pneumococcal), Mycobacterium tuberculosis (TB), Haemophilus influenzae Type B (Hib), Migraine, Motor Neurone Disease (Amyotrophic Lateral Sclerosis/Lou Gehrig's Disease, Multiple sclerosis, Nausea, Neuropathy, Pain, Neuralgia, Fibromyalgia, Paralysis, Parkinson's disease, Restless leg syndrome, Spinal cord, Stroke, Stuttering, Traumatic Brain Injury, Vertigo, Weakness, plus other CNS indications. In Global Central Nervous System Partnering 2016 to 2023, available deals and contracts are listed by: Headline value Upfront payment value Royalty rate value Stage of development at signing Deal component type Technology type Specific therapy indication Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand. The Global Central Nervous System Partnering 2016-2023 report provides comprehensive access to available deals and contract documents for over 1,700 central nervous system deals. Analyzing actual contract agreements allows assessment of the following: What are the precise rights granted or optioned? What is actually granted by the agreement to the partner company? What exclusivity is granted? What is the payment structure for the deal? How are the sales and payments audited? What is the deal term? How are the key terms of the agreement defined? How are IPRs handled and owned? Who is responsible for commercialization? Who is responsible for development, supply, and manufacture? How is confidentiality and publication managed? How are disputes to be resolved? Under what conditions can the deal be terminated? What happens when there is a change of ownership? What sublicensing and subcontracting provisions have been agreed? Which boilerplate clauses does the company insist upon? Which boilerplate clauses appear to differ from partner to partner or deal type to deal type? Which jurisdiction does the company insist upon for agreement law? Selection of Companies Mentioned 1ST Biotherapeutics 2M 3M Drug Delivery Systems 3PrimeDx 3SBio 4SC Discovery 7D Surgical 23andMe A&B Company A*STAR Agency for Science Technology and Research Aarhus University Hospital Abbott Laboratories Abbvie AbCellera Abeona Therapeutics Abide Therapeutics Ablynx Ab Medica Abzena ACADIA Pharmaceuticals Accelerated Cure Project for MS Accelovance Accera Pharmaceuticals Acella Pharmaceuticals Acerus Acetylon Pharmaceuticals AC Immune Acorda Therapeutics Actavis (acquired by Watson) Actelion Acticor Biotech Acturum Life Acura Pharmaceuticals AcuraStem AdAlta Adamas Pharmaceuticals Adaptive Health Adare Pharmaceuticals Addex Therapeutics Adept Neuro Advanced Cooling Therapy Advanced Technologies Solutions Advantage Consumer Healthcare Adventus Ventures Aeon Bioscience Aequus Pharmaceuticals Aeromics AEterna Zentaris Aethlon Medical Affilogic AFFiRiS Afraxis AFT Pharmaceuticals AgeX Therapeutics Agilent Technologies Agilis Biotherapeutics Aguettant Aiforia Technologies AiPing Pharmaceutical AirWare Labs AKC Canine Health Foundation Akorn Akrimax Pharmaceutical Albany Molecular Research Alberta Health Services Albert Einstein College of Medicine Alcyone Lifesciences Alder Biopharmaceuticals Alector Aleva Neurotherapeutics Alexion Pharmaceuticals Alfa Wassermann AliveGen Alkahest Alkermes Allen Institute for Brain Science Allergan Allergan (name changed from Actavis) Allied Healthcare Products Alnylam Pharmaceuticals ALS Association Alseres Pharmaceuticals ALS Finding a Cure Foundation Altair Altus Formulation AlzeCure Pharma Alzheimer's Association Alzheimer's Drug Discovery Foundation Alzheimers Research UK Amarantus BioSciences Ambu Amedica Amendia American Academy of Neurology American Association of Neuromuscular & Electrodiagnostic Medicine American College of Emergency Physicians American College of Physicians Foundation American Heart/Stroke Association American Heart Association American Migraine Foundation American National Multiple Sclerosis Society American Parkinson Diseases Association American Speech-Language-Hearing Association Amgen Amicus Therapeutics Amneal Pharmaceuticals AmorChem Amydis Diagnostics Amylgen AnaBios Analytical Testing Laboratory Anavex Life Sciences ANI Pharmaceuticals Annette Funicello Research Fund for Neurological Diseases (AFRFND) Annovis Bio AnthroTronix Antibe Therapeutics Antidote Aphios ApiFix Appello Pharmaceuticals AppliedVR APR Applied Pharma Research APRINOIA Therapeutics Aptahem Aptinyx Aquinnah Pharmaceuticals Aralez Pharmaceuticals Aratana Therapeutics arGEN-X Arizona State University ArmaGen Array Biopharma Arteaus Therapeutics Artelo Biosciences Arterys Arvelle Therapeutics Asahi Kasei Asana Biosciences Ascend Therapeutics Asceneuron AskAt Asklepios Biopharmaceutical Aspen Holding Assertio Therapeutics Association for Frontotemporal Degeneration Astellas Pharma Astellas Pharma Europe Asterias Biotherapeutics Astex Pharmaceuticals AstraZeneca ATAI Life Sciences Atara Biotherapeutics Ataxion Athersys Atnahs Pharma Aucta Pharmaceuticals Aural Analytics Aurora Cannabis Austin Health Australian Imaging Biomarker & Lifestyle Flagship Study of Ageing (AIBL) Australian Research Council Avanos Medical Avella Avenue Therapeutics AveXis AXIM Biotechnologies AxoSim Axovant Sciences Axsome Therapeutics Axxess Pharma Aziyo Biologics Bachem Bachmann-Strauss Dystonia & Parkinson Foundation Baergic Bio Bain Capital Banyan Biomarkers Baudry Laboratory Baxter International Bayer Baylor College Baylor College of Medicine B Braun BD Consultancy Becton Dickinson Beijing Leadman Biochemistry Ben-Gurion University BenevolentAI Benvenue Medical Berg Best Choice Beyond Batten Disease Foundation Bhang Bial BIA Separations Biedermann Motech Bio-Techne BioArctic Neuroscience biOasis Technologies BioAxone Therapeutic Biocodex BIOCORP BioCrossroads Biodextris Biodirection Biofourmis Biogen Biohaven Pharmaceutical Holding Biohealth Innovation Bioinn Molecular Diagnosis BioLamina BiolineRX BioMarin Pharmaceutical Biomedical Advanced Research and Development Authority BioMedical Research BioMed X Innovation Center BioMotiv Bionik Laboratories Bionomics Bionure Biopharmaceuticals Australia BioQ Pharma Bioscience Pharma Partners BioSpring BioSyent Pharma BioTie Therapies Biotoscana Farma Biscayne Neurotherapeutics Blackfynn Blackrock Microsystems Blackrock NeuroMed BlackThorn Therapeutics Blinktbi Bloom Science BlueRock Therapeutics Boehringer Ingelheim Boston Scientific Boston University Boston University School of Medicine Bpifrance Bracket Braeburn Pharmaceuticals Brain and Spine Institute BRAINBox Solutions BRAIN Initiative BrainLAB BrainScope BrainStorm Cell Therapeutics Brainsway Brain Treatment Center San Diego Brammer Bio Breathe Active BridgeBio Pharma Brigham and Women's Hospital Bristol-Myers Squibb Broad Institute Brooks Automation Brown University Bruker C2N Diagnostics C4 Therapeutics C4X Discovery Cactus Semiconductor Cadence Biomedical Cadence Pharmaceuticals Cadila Pharmaceuticals Cal-BRAIN Calico California Institute for Biomedical Research California Institute for Regenerative Medicine California Institute of Technology Calmare Therapeutics Calox de Costa Rica Camargo Pharmaceutical Services Camarus Cambridge Cognition Cambridge Commodities Camino Partnership CAMP4 Therapeutics Canadian Institutes of Health Research Canadian Physiotherapy Association Canbex Therapeutics Canigma CannaKids CannaRoyalty Cellectricon Celltrion Cellular Dynamics International Cellvation Censo Biotechnologies Center for iPS Cells Research and Application Center for Sensorimotor Neural Engineering Center for Technology and Innovation in Pediatrics (CTIP) Center for the Advancement of Science in Space Centinel Spine Centogene Centre for Commercialization of Regenerative Medicine (CCRM) Centre for Drug Research and Development (CDRD) Centre Hospital University - Bordeaux Centrexion Centro de Investigacion Biomedica en Red de Salud Mental Century Medical CerebraCell Cerebral Therapeutics Cerecor CereHealth Cerevel Therapeutics CerSci Therapeutics Certainty Health Cerveau Technologies Cervel Neurotech Champalimaud Foundation Chaperone Technologies Charcot-Marie-Tooth Association Charles River Associates Charles River Laboratories Charleston Laboratories ChemDiv ChemoCentryx Children's Hospital Boston Children's Hospital of Pittsburgh Foundation Children's Hospital Of Wisconsin Children's Minnesota Children's Research Institute ChoiceSpine Christie Medical Christopher & Dana Reeve Foundation Chromocell Chronos Therapeutics Chugai Pharmaceutical Cincinnati Children's Hospital Medical Center Cipher Pharmaceuticals Cipla Medpro Circuit Therapeutics Citizens United for Research in Epilepsy City of Hope Clene Nanomedicine Cleveland Clinic Cleveland Diabetes Care Clevexel Pharma Clinatec Clinical Ink Clinical Laserthermia Systems (CLS) Clinical Network Services Clinigen Clinipace Worldwide Clinvest Cloud Pharmaceuticals CluePoints Cobra Biologics Cofactor Genomics Cognition Therapeutics CogState Cohen Veterans Bioscience Colby College Colgate University Collegium Pharmaceuticals Colorado HealthOP Columbia University Columbia University Medical Center CombiGene Compassionate Care Center of New York Compass Point Research Complement Pharma Compumedics Concordia Healthcare Confo Therapeutics Congenica Congressman Chaka Fattah Context Therapeutics Convelo Therapeutics Convergence Pharmaceuticals Cook Biotech Corbin Therapeutics Corestem Corium International Coronado Biosciences Corsair Innovations CorTechs Labs Cortexyme Corvida Medical Courtagen Life Sciences Covis Pharmaceutical Cranford Pharmaceuticals CRC Health Creatori Health CRISPR Therapeutics Cronos Group Crossbeta Biosciences Crown Laboratories CSPC Pharmaceutical Group Cumberland Pharmaceuticals CURE Pharmaceutical Dekel Pharmaceuticals Denali Therapeutics Denovo Biopharma Department of Defense Department of Health and Human Services Department of Veterans Affairs DepoMed DePuy DiaMedica DiamiR Dicerna Pharmaceuticals Diego Pellicer Dixi DJO Global DKSH Doctor's Medical Domain Therapeutics Dong-A Pharmaceutical Dr. Reddy's Laboratories Dr. Stephen Cook Draeger Safety Diagnostics DrChrono DuChemBio Duke-NUS Graduate Medical School Singapore Duke University Durect DyNAbind Dystonia Europe DZNE German Center for Neurodegenerative Diseases E-Scape Bio E-Therapeutics Eagle Pharmaceuticals Early Signal Foundation Eastar Industries ECM Therapeutics EDAP TMS Edge Therapeutics Editas Medicine Edith Cowan University (ECU) eemagine Egalet EicOsis Eisai Eisai Inc Ekso Bonics ELC Group Electrical Geodesics ElectroCore Elekta Eli Lilly Elite Pharmaceuticals ElMindA Ember Therapeutics EMD Serono EMMAC Life Sciences Emory University Empatica EMS Emulate Enamine Encoded Therapeutics Endo International Endonovo Therapeutics Endo Pharmaceuticals Endotronix eNeura Therapeutics Enigma Biomedical Entia Biosciences Epic Pharmaceuticals Epilepsy Foundation (EF) Epilepsy Society Essex Bio-Technology Esteve Eton Pharmaceuticals Eureka Eurostars Euroimmun European Commission European Parkinson's Disease Association European Union Evidation Health Evogen Evotec Ewopharma Exactech Exeltis Exosome Sciences Expesicor Ezose Sciences F-Star FAAH Pharma Fast Forward FastFunds Financial Federal Ministry of Education and Research (BMBF) Feinstein Institute for Medical Research Ferring Pharmaceuticals FightMND Firsthand Technology Fitabase FitBit Flexion Therapeutics Flint Rehabilitation Devices Florey Institute of Neuroscience and Mental Heath Florida Atlantic University Research Flowonix Flywheel Fondazione Telethon Food and Drug Administration (FDA) Forbius Forest Pharmaceuticals FORMA Therapeutics Fortress Biotech Forward Pharma Fosun Pharmaceutical Foundation For Angelman Syndrome Therapeutics Foundation for Mitochondrial Medicine Foundation for the National Institutes of Health (FNIH) Fresenius Kabi Pharmaceuticals Fritz Clinic FSD Pharma Fudan University Fukuda Denshi Fundacion Universidad Torcuato Di Tella Fuzionaire Diagnostics Gain Therapeutics Galapagos Galen Galena Biopharma GB Sciences GE Healthcare Geisinger Medical Center Genea Biocells GeneData Genentech General Electric (GE) Gene Therapy Research Institution Genethon GeNeuro Genmab Genomics Genomind Genzyme Geo-Med George Washington University Georgia Institute of Technology Gestion Univalor Gilead Sciences Ginkgo BioWorks GlaxoSmithKline Glialogix Global Alliance for Innovation in Neuroscience Global Drug Development Centre (GDCC) China Global Kinetics GM Medical GNS Healthcare Gold Coast Therapeutics Golden Meditech Goodwin Biotechnology Google And More For more information about this report visit About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Media Contact: Research and Markets Laura Wood, Senior Manager [email protected] For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Logo - SOURCE Research and Markets